REG - China Pacific Insur. - Resignation of Director of the Board

China Pacific Insurance CoAnnouncement

24/06/2025 10:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250624:nRSX1757Oa&default-theme=true

RNS Number : 1757O  China Pacific Insurance Grp Co. Ltd  24 June 2025

24 June 2025

CHINA PACIFIC INSURANCE (GROUP) CO., LTD.

(A joint stock company incorporated in the People's Republic of China with
limited liability)

Resignation of Director of the Board

The board of directors (the "Board") of China Pacific Insurance (Group) Co.,
Ltd. (the "Company" or "CPIC") hereby announces that Mr. XIE Weiqing ("Mr.
XIE") has submitted his resignation to the Board, resigning from his position
as non-executive director, member of the Audit and Related Party Transaction
Control Committee of the Board and member of the Technological Innovation and
Consumer Rights Protection Committee of the Board due to work reasons. The
resignation of Mr. XIE took effect on 24 June 2025.

 

Mr. XIE has confirmed that he has no disagreement with the Board and there is
no matter in respect of his resignation that needs to be brought to the
attention of the shareholders and creditors of the Company. During his tenure,
Mr. XIE performed his duties and fulfilled his responsibilities. The Board of
the Company would like to express its sincere gratitude to Mr. XIE for his
contributions to the Company.

 

 

 

By Order of the Board of Directors

        China Pacific Insurance (Group) Co., Ltd.

FU Fan

Chairman

 

 

About CPIC

CPIC is a joint stock company established under the laws of the People's
Republic of China with limited liability.

CPIC's registered office is located at 1 South Zhongshan Road, Huangpu
District, Shanghai, the People's Republic of China.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGCGDLDDDDGUS